Evaluation of Anti-TBGL Antibody in the Diagnosis of Tuberculosis Patients in China

Figure 2

Elevated titers in association with different clinical findings. (a), (b), and (c) display findings of PTB-cavity versus PTB-noncavity, PTB-bronchiectasis versus PTB-nonbronchiectasis, and PTB-smear-negative versus PTB-smear-positive, respectively. A value less than 0.05 indicates a significant difference between 2 groups by nonparametric -test. (L), (M), and (R) referred to anti-TBGL IgG, anti-TBGL IgA, and anti-LAM IgG, respectively.

(a)

(b)

(c)